DexCom (DXCM)
(Delayed Data from NSDQ)
$111.94 USD
-0.19 (-0.17%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $112.03 +0.09 (0.08%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 241 - 260 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Marching Toward $1 Billion in Revenue; Raising PT to $105; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Recent Trends Bode Well for Our Covered Names Reporting This Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical survey of 1,664 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - 2Q15 Preview: MedTech Underlying Fundamentals Healthy and Outlook for 2H15
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
2Q15 Preview: MedTech Underlying Fundamentals Healthy and Outlook for 2H15 Remains Positive
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 2Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q1 revenue above estimates, EPS dragged down by compensation, reiterate SELL
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Rapidly Expanding Installed Base Bodes Well For 2015; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Feltl CGM Project: Historical survey of 1,552 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Proprietary Survey Indicates DXCM''s G4 to Gain Share and CGM Technology to Experience Greater Adoption; Raising PT to $80
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
1Q15 Preview: Trends Look Better Than Initially Expected
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Takeaways from J-J''s 1Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Positive for Insulet and Tandem; Raising PT of PODD to $38
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 1Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
DXCM''s Quest for a Dosing Claim May Benefit from FDA''s New Expedited Access Program; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Quest for a Dosing Claim May Benefit from FDA''s New Expedited Access Program; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.